Skip to content

The effect of whole body electrical muscle stimulation on spinal diseases

Exploring the Role of Whole Body Electrical Muscle Stimulation in Weight Loss and Functional Enhancement for Individuals with Degenerative Joint Diseases of the Spine and Limited Physical Activity and High Body Mass Index

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250513065709N1
Enrollment
108
Registered
2025-08-03
Start date
2025-08-06
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodegenerative Spine Diseases. Subacute combined degeneration of spinal cord in diseases classified elsewhere

Interventions

Intervention 1: Control group: Participants only receive standard care including education on ergonomic principles and spinal care, light stretching and strengthening exercise program appropriate to p

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 79 Years

Inclusion criteria

Inclusion criteria: Degenerative spinal disease diagnosed clinically and according to radiologic findings Patients with limited mobility to perform activities according to the WIQ index (Score <45) Aged 50-79 years old Ability to understand and implement intervention instructions BMI equal to or greater than 30 kg/m2 Willingness to participate and signing an informed consent form

Exclusion criteria

Exclusion criteria: Established neuromuscular disease Established psychiatric disorders Diagnosed balance disorders and vertigo History of spinal surgery in the past 6 months Severe or uncontrolled cardiovascular disease, including uncontrolled blood pressure (systolic blood pressure > 180 mmHg or diastolic > 110 mmHg) or uncontrolled diabetes (HbA1c > 8%). Pregnancy or breastfeeding. Use of anticoagulants. Presence of metal implants in the body (except dental implants). Presence of red flags of back pain in patients. Presence of advanced degenerative knee disease Failure to continue training within eight weeks and willingness to withdraw from the study (Dropping) Active rheumatic diseases (such as rheumatoid arthritis, lupus, ankylosing spondylitis) that are not under control

Design outcomes

Primary

MeasureTime frame
Walking Impairment Questionnaire (WIQ) Score. Timepoint: Baseline and 8 weeks. Method of measurement: Standardized Walking Impairment Questionnaire (WIQ) questionnaire.;Low Back Pain Intensity. Timepoint: baseline and 8 weeks. Method of measurement: Numerical Rating Scale (NRS).;Health-Related Quality of Life. Timepoint: baseline and 8 weeks. Method of measurement: Short Form-36 questionnaire (SF-36).;6-Minute Walk Test Distance. Timepoint: baseline and 8 weeks. Method of measurement: Measured as total distance walked in meters over 6 minutes on flat 30-meter course.;Two-Stage Treadmill Test Duration. Timepoint: baseline and 8 weeks. Method of measurement: Measured as walking time in seconds during second stage at 3 km/h with 10% incline.;Anthropometric Measures. Timepoint: baseline and 8 weeks. Method of measurement: BMI, waist Circumference, and hip Circumference will be measured by standardized meter and scale.;Body Composition. Timepoint: baseline and 8 weeks. Method of measurement: segmental direct multi-frequency bioelectrical impedance analysis.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Karimabadi

Kerman University of Medical Sciences

Rkarimabadi09@gmail.com+98 34 3226 5433

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026